Medicines Co. Shares Up 26% After Bloomberg Report
19 Novembre 2019 - 2:57PM
Dow Jones News
By Michael Dabaie
Medicines Co. (MDCO) shares rose 26% to $73.98 premarket.
Bloomberg reported earlier that Medicines Co. has attracted
takeover interest from suitors, including from Novartis AG (NVS),
citing people familiar with the matter.
Novartis has been holding talks about a potential acquisition of
the company, according to the people, Bloomberg reported. Novartis
is conducting due diligence on the company, one of the people said,
according to the Bloomberg report.
Officials from Medicines Co. and Novartis declined to
comment.
Medicines Co. shares rose 13% Monday. The company said Monday
that the ORION-9 study of inclisiran in heterozygous familial
hypercholesterolemia patients showed durable low-density
lipoprotein cholesterol lowering with twice-yearly dosing.
Write to Michael Dabaie at michael.dabaie@wsj.com
(END) Dow Jones Newswires
November 19, 2019 08:42 ET (13:42 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Grafico Azioni Medicines (NASDAQ:MDCO)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Medicines (NASDAQ:MDCO)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Medicines Company (NASDAQ): 0 articoli recenti
Più Medicines Company Articoli Notizie